Prelude Therapeutics Inc (PRLD) Insider Trading
- $6,023,784.44
- $7,511,453.10
- March 25, 2025
- Krishna Vaddi
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 25, 2025 | CEO | 675,000 | $0.69 | Buy | $465,750.00 | |
| March 25, 2025 | Insider | 100,000 | $0.69 | Buy | $69,000.00 | |
| March 12, 2025 | CEO | 47,500 | $0.71 | Buy | $33,725.00 | |
| Dec. 30, 2024 | CEO | 10,000 | $1.20 | Buy | $12,000.00 | |
| Dec. 23, 2024 | Insider | 60,000 | $1.37 | Buy | $82,200.00 | |
| Dec. 20, 2024 | Insider | 3,075 | $1.15 | Buy | $3,536.25 | |
| Dec. 19, 2024 | CFO | 25,000 | $0.91 | Buy | $22,750.00 | |
| Dec. 18, 2024 | CEO | 100,000 | $0.93 | Buy | $93,000.00 | |
| May 24, 2023 | CEO | 1,000 | $5.01 | Buy | $5,010.00 | |
| May 22, 2023 | Director | 869,565 | $5.75 | Buy | $4,999,998.75 | |
| April 6, 2023 | CMO | 13,280 | $6.12 | Sell | $81,273.60 | |
| Dec. 20, 2022 | CEO | 19,188 | $5.13 | Buy | $98,434.44 | |
| Dec. 8, 2022 | CFO | 10,000 | $4.76 | Buy | $47,600.00 | |
| June 1, 2022 | CFO | 10,000 | $4.23 | Buy | $42,300.00 | |
| Dec. 13, 2021 | EVP | 4,000 | $12.12 | Buy | $48,480.00 | |
| Nov. 16, 2021 | EVP | 28,751 | $15.88 | Sell | $456,565.88 | |
| Oct. 5, 2021 | Insider | 15,000 | $30.96 | Sell | $464,400.00 | |
| Sept. 7, 2021 | Insider | 15,000 | $36.69 | Sell | $550,350.00 | |
| Sept. 2, 2021 | EVP | 17,000 | $41.68 | Sell | $708,560.00 | |
| Aug. 26, 2021 | Insider | 1,700 | $35.19 | Sell | $59,823.00 | |
| Aug. 25, 2021 | CFO | 8,333 | $33.34 | Sell | $277,822.22 | |
| Aug. 5, 2021 | Insider | 15,000 | $31.09 | Sell | $466,350.00 | |
| July 27, 2021 | Insider | 20,000 | $35.47 | Sell | $709,400.00 | |
| July 6, 2021 | Insider | 15,000 | $27.47 | Sell | $412,050.00 | |
| June 7, 2021 | Insider | 15,000 | $32.44 | Sell | $486,600.00 | |
| May 25, 2021 | CFO | 8,333 | $34.27 | Sell | $285,571.91 | |
| May 7, 2021 | Insider | 10,000 | $40.82 | Sell | $408,200.00 | |
| May 5, 2021 | Insider | 15,000 | $40.14 | Sell | $602,100.00 | |
| April 29, 2021 | EVP | 3,295 | $40.29 | Sell | $132,755.55 | |
| April 19, 2021 | Insider | 25,000 | $30.89 | Sell | $772,250.00 | |
| April 7, 2021 | insider | 15,370 | $39.31 | Sell | $604,194.70 | |
| April 7, 2021 | EVP | 828 | $40.08 | Sell | $33,186.24 |
Insiders are both buying and selling Prelude Therapeutics Inc stock.
The insider traders at Prelude Therapeutics Inc are: David J Mauro, Krishna Vaddi, Andrew Combs, Peggy Scherle, Christopher Pierce, Brian Piper, Laurent Chardonnet, Jane Huang, Bryant David Lim, David J. Mauro, Orbimed Advisors Llc, and Deborah Morosini
The most active insider trader at Prelude Therapeutics Inc is David J Mauro with 6 trades.
David J Mauro has sold the most Prelude Therapeutics Inc stock with a total value of $3,806,450.00.
Orbimed Advisors Llc has bought the most Prelude Therapeutics Inc stock with a total value of $9,999,997.50.
The most recent insider trade for Prelude Therapeutics Inc was on March 25, 2025.
The single biggest insider buy for Prelude Therapeutics Inc was from Orbimed Advisors Llc with a total value of $4,999,998.75 on May 22, 2023.
The single biggest insider sell for Prelude Therapeutics Inc was from David J Mauro with a total value of $772,250.00 on April 19, 2021.